A case of L-tryptophan-induced eosinophilia-myalgia resulting in death.
A syndrome of eosinophilia and myalgias associated with the ingestion of L-tryptophan has recently been described. In a large majority of the cases reported to the Centers for Disease Control thus far, discontinuation of L-tryptophan consumption has resulted in complete resolution of symptoms. The author presents a case of L-tryptophan-induced eosinophilia-myalgia syndrome which was progressive despite discontinuation of the L-tryptophan. The condition was refractory to treatment and ultimately resulted in the death of the patient.
Marks
D R
DR
Department of Internal Medicine, Greenwich Hospital.
D000368:Aged; D004802:Eosinophilia / Q000139:chemically induced* / Q000401:mortality; D005260:Female; D006801:Humans; D009135:Muscular Diseases / Q000139:chemically induced*; D010146:Pain / Q000139:chemically induced*; D013577:Syndrome; D014364:Tryptophan / Q000009:adverse effects*
D014364:Tryptophan